These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 35441076)
1. Virucidal activity and mechanism of action of cetylpyridinium chloride against SARS-CoV-2. Okamoto N; Saito A; Okabayashi T; Komine A J Oral Maxillofac Surg Med Pathol; 2022 Nov; 34(6):800-804. PubMed ID: 35441076 [TBL] [Abstract][Full Text] [Related]
2. Virucidal activity of oral care products against SARS-CoV-2 Komine A; Yamaguchi E; Okamoto N; Yamamoto K J Oral Maxillofac Surg Med Pathol; 2021 Jul; 33(4):475-477. PubMed ID: 33643836 [TBL] [Abstract][Full Text] [Related]
3. V367F Mutation in SARS-CoV-2 Spike RBD Emerging during the Early Transmission Phase Enhances Viral Infectivity through Increased Human ACE2 Receptor Binding Affinity. Ou J; Zhou Z; Dai R; Zhang J; Zhao S; Wu X; Lan W; Ren Y; Cui L; Lan Q; Lu L; Seto D; Chodosh J; Wu J; Zhang G; Zhang Q J Virol; 2021 Jul; 95(16):e0061721. PubMed ID: 34105996 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of Cetylpyridinium Chloride mouthwash against SARS-CoV-2: A systematic review of randomized controlled trials. D'Amico F; Moro M; Saracino M; Marmiere M; Cilona MB; Lloyd-Jones G; Zangrillo A Mol Oral Microbiol; 2023 Jun; 38(3):171-180. PubMed ID: 36808889 [TBL] [Abstract][Full Text] [Related]
5. Mouthwashes with CPC Reduce the Infectivity of SARS-CoV-2 Variants In Vitro. Muñoz-Basagoiti J; Perez-Zsolt D; León R; Blanc V; Raïch-Regué D; Cano-Sarabia M; Trinité B; Pradenas E; Blanco J; Gispert J; Clotet B; Izquierdo-Useros N J Dent Res; 2021 Oct; 100(11):1265-1272. PubMed ID: 34282982 [TBL] [Abstract][Full Text] [Related]
6. Comparison of Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein Binding to ACE2 Receptors from Human, Pets, Farm Animals, and Putative Intermediate Hosts. Zhai X; Sun J; Yan Z; Zhang J; Zhao J; Zhao Z; Gao Q; He WT; Veit M; Su S J Virol; 2020 Jul; 94(15):. PubMed ID: 32404529 [TBL] [Abstract][Full Text] [Related]
7. Inactivation of SARS-CoV-2 through Treatment with the Mouth Rinsing Solutions ViruProX Koch-Heier J; Hoffmann H; Schindler M; Lussi A; Planz O Microorganisms; 2021 Mar; 9(3):. PubMed ID: 33802603 [TBL] [Abstract][Full Text] [Related]
8. The chaperone GRP78 is a host auxiliary factor for SARS-CoV-2 and GRP78 depleting antibody blocks viral entry and infection. Carlos AJ; Ha DP; Yeh DW; Van Krieken R; Tseng CC; Zhang P; Gill P; Machida K; Lee AS J Biol Chem; 2021; 296():100759. PubMed ID: 33965375 [TBL] [Abstract][Full Text] [Related]
10. Screening of inhibitors against SARS-CoV-2 spike protein and their capability to block the viral entry mechanism: A viroinformatics study. Farouk AE; Baig MH; Khan MI; Park T; Alotaibi SS; Dong JJ Saudi J Biol Sci; 2021 Jun; 28(6):3262-3269. PubMed ID: 33654454 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of a Mouthwash Containing CHX and CPC in SARS-CoV-2-Positive Patients: A Randomized Controlled Clinical Trial. Bonn EL; Rohrhofer A; Audebert FX; Lang H; Auer DL; Scholz KJ; Schuster P; Wenzel JJ; Hiller KA; Buchalla W; Gottsauner JM; Vielsmeier V; Schmidt B; Cieplik F J Dent Res; 2023 Jun; 102(6):608-615. PubMed ID: 36942423 [TBL] [Abstract][Full Text] [Related]
12. Competitive SARS-CoV-2 Serology Reveals Most Antibodies Targeting the Spike Receptor-Binding Domain Compete for ACE2 Binding. Byrnes JR; Zhou XX; Lui I; Elledge SK; Glasgow JE; Lim SA; Loudermilk RP; Chiu CY; Wang TT; Wilson MR; Leung KK; Wells JA mSphere; 2020 Sep; 5(5):. PubMed ID: 32938700 [TBL] [Abstract][Full Text] [Related]